About Esvy Life Sciences Private Limited
Data last updated:
Esvy Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2019PTC134767. Its GSTIN is 36AAFCE5994B1ZJ (Telangana).
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹1.14 Cr. It is led by directors Prabhu Gajawada and Neeraja Peddi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Flat No 305 Sagarview Apartment 6 – 3 – 1132 Bs Maktha, Hyderabad, Telangana, India – 500016.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.21 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹12.76 Lakh (net margin 5.8%) and EBITDA of ₹17.76 Lakh (EBITDA margin 8.1%). Revenue has grown at a compounded annual rate (CAGR) of 53% over three years and 28% over five years.
For more details, the company can be reached via its website myesvy.com.
Company details
Contact details
Esvy Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its website is myesvy.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFlat No 305 Sagarview Apartment 6 – 3 – 1132 Bs Maktha, Hyderabad, Telangana, India – 500016
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Esvy Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Esvy Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Esvy Life Sciences Private Limited, buy the company report.
Financials of Esvy Life Sciences Private Limited
FY 2024 filings availableEsvy Life Sciences Private Limited reported revenue of ₹2.21 Cr (up 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 28% over five years, including 20% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.76 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.76 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.1% | ||||
| Net Profit Margin | 5.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Esvy Life Sciences Private Limited, buy the company report.
Board of directors of Esvy Life Sciences Private Limited
Esvy Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prabhu Gajawada Also directs: Esvy Purple Private Limited, Adwagons Advertising Private Limited | Director | 13 Aug 2019 | 7 Years 2 Months | Current |
| Neeraja Peddi Also directs: Esvy Purple Private Limited | Director | 13 Aug 2019 | 7 Years 2 Months | Current |
Peer comparison
Esvy Life Sciences Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Esvy Life Sciences Private Limitedthis company | ₹2.21 Cr (FY 2025) | ₹12.76 Lakh | 5.8% | 20.0% | Hyderabad, Telangana, India | |
| Ciel Pharma Private Limited | ₹2.2 Cr (FY 2022) | 20.0% | Lucknow, Uttar Pradesh, India | |||
| Hariansh Pharmaceuticals Private Limited | ₹2.19 Cr (FY 2024) | 270.0% | Nashik, Maharashtra, India | |||
| Cellbless Healthcare Private Limited | ₹2.19 Cr (FY 2023) | 0.0% | Lucknow, Uttar Pradesh, India | |||
| Maccare Drugs Private Limited | ₹2.18 Cr (FY 2025) | 12.0% | Meerut, Uttar Pradesh, India |
To see the full peer comparison of Esvy Life Sciences Private Limited, buy the company report.
Auditor
Esvy Life Sciences Private Limited is audited by A N RAO AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A N RAO AND ASSOCIATES | FY 2023 | 014861S |
Shareholding
The shareholding of Esvy Life Sciences Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Esvy Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Esvy Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Esvy Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Esvy Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCE5994B1ZJ | Telangana | Active | 23 Aug 2019 |
To see the full GST registrations and return filing status of Esvy Life Sciences Private Limited, buy the company report.
Recent activity
Esvy Life Sciences Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Neeraja Peddi was appointed as Director on 13 Aug 2019.
Frequently asked questions
Esvy Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 August 2019 (7+ years old) and is registered under CIN U24230TG2019PTC134767.
Esvy Life Sciences has 2 current directors:
- Prabhu Gajawada - Director
- Neeraja Peddi - Director
The latest financial statements of Esvy Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Esvy Life Sciences is 36AAFCE5994B1ZJ, registered in Telangana.
The CIN (Corporate Identification Number) of Esvy Life Sciences is U24230TG2019PTC134767. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Esvy Life Sciences was incorporated on 13 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Esvy Life Sciences by revenue are Ciel Pharma Private Limited, Hariansh Pharmaceuticals Private Limited, Cellbless Healthcare Private Limited, Maccare Drugs Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Neeraja Peddi was appointed as Director on 13 Aug 2019. Prabhu Gajawada was appointed as Director on 13 Aug 2019.
Esvy Life Sciences can be reached through the website myesvy.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Esvy Life Sciences is at Flat No 305 Sagarview Apartment 6 – 3 – 1132 Bs Maktha, Hyderabad, Telangana, India – 500016.
Esvy Life Sciences operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
